Gemcitabine 38 mg/mL (Gemcitabine INJECTION, SOLUTION) 38 mg/mL

Gemcitabine 38 mg/mL is an injectable solution used for various medical treatments. This single-dose vial is manufactured by Hospira, Inc. in the USA.

Strength

38 mg/mL

Pack Size

1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0182-25) / 52.6 mL in 1 VIAL, SINGLE-DOSE

Manufacturer / TM Owner

Hospira, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Gemcitabine 38 mg/mL is primarily used in intravenous treatments. It is often prescribed for certain types of cancer, helping to slow or stop the growth of cancer cells. The specific uses of Gemcitabine 38 mg/mL should be determined by a healthcare professional based on individual patient needs.

Side Effects

Common effects of Gemcitabine 38 mg/mL may include fatigue, nausea, and vomiting. Some patients may experience fever or swelling at the injection site. These effects can vary from person to person, and it is important to discuss any concerns with a healthcare provider.

Precautions & Warnings

Gemcitabine 38 mg/mL should be handled with care, as it is a potent medication. It is important to follow proper storage and disposal guidelines to ensure safety. Patients should inform their healthcare provider about any allergies or medical conditions before starting treatment.

Avoid Interactions

Gemcitabine 38 mg/mL may interact with other medications, including certain chemotherapy drugs. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and other substances may also affect the efficacy of Gemcitabine 38 mg/mL.

Frequently Asked Questions

Gemcitabine 38 mg/mL is used in intravenous treatments, often for certain types of cancer.

Gemcitabine 38 mg/mL is administered intravenously by a healthcare professional.

Common effects may include fatigue, nausea, vomiting, and fever.

Yes, it may interact with other medications, including certain chemotherapy drugs.

It should be handled with care, and proper storage and disposal guidelines should be followed.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.